The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
VolitionRX Ltd (AMEX: VNRX) closed the day trading at $0.29 down -9.39% from the previous closing price of $0.32. In other words, the price has decreased by -$9.39 from its previous closing price. On the day, 1.62 million shares were traded. VNRX stock price reached its highest trading level at $0.3187 during the session, while it also had its lowest trading level at $0.2892.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 17 ’25 when Reynolds Cameron John bought 20,000 shares for $0.35 per share. The transaction valued at 7,000 led to the insider holds 2,554,847 shares of the business.
Reynolds Cameron John bought 110,000 shares of VNRX for $56,100 on Oct 14 ’25. The President and CEO now owns 2,534,847 shares after completing the transaction at $0.51 per share. On Oct 14 ’25, another insider, Innes Guy Archibald, who serves as the Director of the company, bought 96,153 shares for $0.51 each. As a result, the insider paid 49,038 and bolstered with 1,062,967 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VNRX now has a Market Capitalization of 35796656 and an Enterprise Value of 45541396. For the stock, the TTM Price-to-Sale (P/S) ratio is 24.35. Its current Enterprise Value per Revenue stands at 30.938 whereas that against EBITDA is -2.103.
Stock Price History:
The Beta on a monthly basis for VNRX is 1.26, which has changed by -0.45762712 over the last 52 weeks, in comparison to a change of 0.12607694 over the same period for the S&P500. Over the past 52 weeks, VNRX has reached a high of $0.94, while it has fallen to a 52-week low of $0.29. The 50-Day Moving Average of the stock is -36.54%, while the 200-Day Moving Average is calculated to be -48.52%.
Shares Statistics:
Over the past 3-months, VNRX traded about 1.19M shares per day on average, while over the past 10 days, VNRX traded about 4112050 shares per day. A total of 109.62M shares are outstanding, with a floating share count of 96.62M. Insiders hold about 21.32% of the company’s shares, while institutions hold 21.27% stake in the company. Shares short for VNRX as of 1763078400 were 362805 with a Short Ratio of 0.30, compared to 1760486400 on 266027. Therefore, it implies a Short% of Shares Outstanding of 362805 and a Short% of Float of 0.38999999999999996.
Earnings Estimates
The stock of VolitionRX Ltd (VNRX) is currently in the spotlight, with 3.0 analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is -$0.04, with high estimates of -$0.04 and low estimates of -$0.04.
Analysts are recommending an EPS of between -$0.2 and -$0.21 for the fiscal current year, implying an average EPS of -$0.2. EPS for the following year is -$0.09, with 4.0 analysts recommending between $0.08 and -$0.15.
Revenue Estimates
6 analysts predict $714.08k in revenue for. The current quarter. It ranges from a high estimate of $868k to a low estimate of $560k. As of. The current estimate, VolitionRX Ltd’s year-ago sales were $191.66kFor the next quarter, 6 analysts are estimating revenue of $875k. There is a high estimate of $1.2M for the next quarter, whereas the lowest estimate is $665k.
A total of 5 analysts have provided revenue estimates for VNRX’s current fiscal year. The highest revenue estimate was $2.15M, while the lowest revenue estimate was $1.8M, resulting in an average revenue estimate of $1.95M. In the same quarter a year ago, actual revenue was $1.23MBased on 6 analysts’ estimates, the company’s revenue will be $12.44M in the next fiscal year. The high estimate is $29.26M and the low estimate is $2.78M.
